Track Your Future Recoveries Withsnaptrade iconConnect Account

Adamas Pharmaceuticals, Inc., Settlement
(NASDAQ: ADMS)
Settlement

Claim Deadline: May 08, 2021

Settlement Fund: $7,500,000

Settlement Class

ALL PERSONS OR ENTITIES THAT PURCHASED ADAMAS PHARMACEUTICALS, INC. COMMON STOCK DIRECTLY IN ADAMAS’ JANUARY 24, 2018, SECONDARY PUBLIC OFFERING PURSUANT TO ADAMAS’ NOVEMBER 21, 2016, REGISTRATION STATEMENT AND JANUARY 24, 2018, PROSPECTUS SUPPLEMENT AND ALL MATERIALS INCORPORATED THEREIN.

Important Documents

Settlement Status

Disbursed

Class Period

January 24, 2018 - May 13, 2019

Settlement Hearing Date

April 13, 2021

Opt-Out Deadline

March 12, 2021

Settlement Website

N/A

Claims Admin

A.B. Data, Ltd.
P.O. Box 173028
Milwaukee, WI 53217
+1 877-203-8960
info@adamasshareholdersettlement.com

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.